Women taking calcium-channel blockers (CCBs) for at least 10 years might be at increased risk of developing breast cancer, according to American researchers who enrolled 880 women, aged between 55 and 74 years, with invasive ductal breast cancer, 1027 with invasive lobular breast cancer and 856 controls. The invest
Please login or register to read the rest of the article and to have access to downloads and comments.